BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27183113)

  • 21. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
    Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
    J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis.
    Lan X; Li S; Gao H; Nanding A; Quan L; Yang C; Ding S; Xue Y
    Onco Targets Ther; 2017; 10():919-926. PubMed ID: 28243127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responses.
    Spodzieja M; Lach S; Iwaszkiewicz J; Cesson V; Kalejta K; Olive D; Michielin O; Speiser DE; Zoete V; Derré L; Rodziewicz-Motowidło S
    PLoS One; 2017; 12(6):e0179201. PubMed ID: 28594868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].
    Han LF; Qiu WM; Hu C; Wang L; Yao HX; Xiong SY; Meng M; Fang Y; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):603-8. PubMed ID: 21029617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator.
    Cai G; Anumanthan A; Brown JA; Greenfield EA; Zhu B; Freeman GJ
    Nat Immunol; 2008 Feb; 9(2):176-85. PubMed ID: 18193050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory role of BTLA and HVEM checkpoint inhibitors in T cell activation in a perciform fish Larimichthys crocea.
    Jin CY; Su N; Hu CB; Shao T; Ji JF; Qin LL; Fan DD; Lin AF; Xiang LX; Shao JZ
    Dev Comp Immunol; 2022 Mar; 128():104312. PubMed ID: 34767880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percentages of CD4+CD161+ and CD4-CD8-CD161+ T cells in the synovial fluid are correlated with disease activity in rheumatoid arthritis.
    Miao J; Zhang K; Qiu F; Li T; Lv M; Guo N; Han Q; Zhu P
    Mediators Inflamm; 2015; 2015():563713. PubMed ID: 25960619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia.
    Sordo-Bahamonde C; Lorenzo-Herrero S; Martínez-Pérez A; Gonzalez-Rodriguez AP; Payer ÁR; González-García E; Aguilar-García C; González-Rodríguez S; López-Soto A; García-Torre A; Gonzalez S
    Cancer Immunol Immunother; 2023 Jul; 72(7):2529-2539. PubMed ID: 37041226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different distribution of CD4 and CD8 T cells in synovial membrane and peripheral blood of rheumatoid arthritis and osteoarthritis patients.
    Pawłowska J; Mikosik A; Soroczynska-Cybula M; Jóźwik A; Łuczkiewicz P; Mazurkiewicz S; Lorczyński A; Witkowski JM; Bryl E
    Folia Histochem Cytobiol; 2009; 47(4):627-32. PubMed ID: 20430731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM.
    Murphy TL; Murphy KM
    Annu Rev Immunol; 2010; 28():389-411. PubMed ID: 20307212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herpesvirus entry mediator-Ig treatment during immunization aggravates rheumatoid arthritis in the collagen-induced arthritis model.
    Pierer M; Schulz A; Rossol M; Kendzia E; Kyburz D; Haentzschel H; Baerwald C; Wagner U
    J Immunol; 2009 Mar; 182(5):3139-45. PubMed ID: 19234211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low B and T lymphocyte attenuator expression on CD4+ T cells in the early stage of sepsis is associated with the severity and mortality of septic patients: a prospective cohort study.
    Shao R; Li CS; Fang Y; Zhao L; Hang C
    Crit Care; 2015 Aug; 19(1):308. PubMed ID: 26329820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptides targeting the BTLA-HVEM complex can modulate T cell immune response.
    Wojciechowicz K; Kuncewicz K; Lisowska KA; Wardowska A; Spodzieja M
    Eur J Pharm Sci; 2024 Feb; 193():106677. PubMed ID: 38128840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses.
    Sakoda Y; Nagai T; Murata S; Mizuno Y; Kurosawa H; Shoda H; Morishige N; Yanai R; Sonoda KH; Tamada K
    J Immunol; 2016 Apr; 196(7):2947-54. PubMed ID: 26912321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
    M'Hidi H; Thibult ML; Chetaille B; Rey F; Bouadallah R; Nicollas R; Olive D; Xerri L
    Am J Clin Pathol; 2009 Oct; 132(4):589-96. PubMed ID: 19762537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of Xinfeng capsule treatment on the number of BTLA(+)T cells and oxidative stress of patients with ankylosing spondylitis].
    Qi Y; Liu J; Zheng L; Cao Y; Wan L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1084-9. PubMed ID: 25270214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BTLA and HVEM cross talk regulates inhibition and costimulation.
    Gavrieli M; Sedy J; Nelson CA; Murphy KM
    Adv Immunol; 2006; 92():157-85. PubMed ID: 17145304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia.
    Sordo-Bahamonde C; Lorenzo-Herrero S; Gonzalez-Rodriguez AP; R Payer Á; González-García E; López-Soto A; Gonzalez S
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33917094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The decline in lung function is associated with a decrease in the number of BTLA⁺ lymphocytes and regulatory T cells in patients with rheumatism].
    Liu J; Wan L; Liu L; Cheng Y; Feng Y; Huang C; Wang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):639-42. PubMed ID: 24909289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural determinants of herpesvirus entry mediator recognition by murine B and T lymphocyte attenuator.
    Nelson CA; Fremont MD; Sedy JR; Norris PS; Ware CF; Murphy KM; Fremont DH
    J Immunol; 2008 Jan; 180(2):940-7. PubMed ID: 18178834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.